Cargando…
Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
Adult human neurodegenerative diseases have no disease-modifying treatments. We used spinocerebellar ataxia type 2 (SCA2), an autosomal dominant polyglutamine disease1, as a model to test RNA-targeted therapies(2) in two SCA2 mouse models. Both models recreate progressive adult-onset dysfunction and...
Autores principales: | Scoles, Daniel R., Meera, Pratap, Schneider, Matthew, Paul, Sharan, Dansithong, Warunee, Figueroa, Karla P., Hung, Gene, Rigo, Frank, Bennett, C. Frank, Otis, Thomas S., Pulst, Stefan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625650/ https://www.ncbi.nlm.nih.gov/pubmed/28405024 http://dx.doi.org/10.1038/nature22044 |
Ejemplares similares
-
ALS-associated genes in SCA2 mouse spinal cord transcriptomes
por: Scoles, Daniel R, et al.
Publicado: (2020) -
Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration
por: Paul, Sharan, et al.
Publicado: (2018) -
A positive feedback loop linking enhanced mGluR function and basal calcium in spinocerebellar ataxia type 2
por: Meera, Pratap, et al.
Publicado: (2017) -
Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice
por: Toonen, Lodewijk J.A., et al.
Publicado: (2017) -
Staufen 1 amplifies proapoptotic activation of the unfolded protein response
por: Gandelman, Mandi, et al.
Publicado: (2020)